Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion type Assertion NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_head.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion description "[Therefore, the SEA D227A-Mx3 diabody is considered to be a promising reagent in specific targeted immunotherapy for BDC and other MUC1-positive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion evidence source_evidence_literature NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion SIO_000772 11845258 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion wasDerivedFrom befree-20140225 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.
- NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_assertion wasGeneratedBy ECO_0000203 NP747578.RAk_IqujAclHmm4OS19Vf8rz8sdEl3rtVy-Bz16_Yj7TQ130_provenance.